Anti-CTLA4 ED (Wincal Biopharm)

N/A

Report date: 2025/02/17 10:33:19

Base Information

Drug NameAnti-CTLA4 ED (Wincal Biopharm)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CTLA4
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsUveal melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWincal Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesWincal Biopharm Inc
Inactive CompaniesN/A
Active IndicationsUveal melanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A